Suwa Kiyomi, Yoshikawa Reiko, Iwasaki Kosuke, Igarashi Ataru
a Pfizer Japan, Inc. , Tokyo , Japan.
b Milliman, Inc. , Tokyo , Japan.
J Med Econ. 2018 May;21(5):443-449. doi: 10.1080/13696998.2018.1426590. Epub 2018 Feb 1.
The short-term effects of smoking cessation (SC) on overall healthcare costs are unclear. This study aimed to compare the short-term medical costs between patients with SC outpatient visits (SCOVs) and those without SCOVs, consisting of SCOV itself and overall medical costs.
This study is a retrospective, observational study using a Japanese employee-based health insurance claims database (January 1, 2005-December 31, 2013). It analyzed individuals who were registered as smokers based on their medical checkup details. It compared the per-patient-per-year (PPPY) medical costs for male smokers who made ≥1 claim for SCOVs with those who made no claims. We also assessed whether the number of SCOVs by male and female smokers impacted medical costs. The Index Year was the year after the first SCOV claim and that after the first registration as a smoker (non-SCOV group). Medical costs were calculated using regression analysis and adjusted for baseline costs.
In Index Year -1, PPPY medical costs for male smokers were ∼USD 323.01 (JPY 36,500, as of November 2017) higher in the SCOV (n = 5,608) vs the non-SCOV (n = 81,721) group; however, by Year 6 the costs were similar. From Year 4-6, PPPY medical costs for SCOVs were lower than those in the adjusted non-SCOV group. For 2,576 male and female smokers in the SCOV group, the average rates of increasing medical costs before and after the SCOV for 1, 2, 3, 4, and 5 SCOVs made were 58%, 44%, 50%, 41%, and 34%, respectively.
The database includes limited data on individuals >65 years. Only SCOVs based on claims data and not on other outcomes were assessed.
Medical costs declined in the short-term following the first SCOV. Attendance at a greater number of SCOVs was associated with a lower increase ratio of medical costs.
戒烟对总体医疗费用的短期影响尚不清楚。本研究旨在比较有戒烟门诊就诊(SCOV)的患者和无SCOV的患者之间的短期医疗费用,包括SCOV本身及总体医疗费用。
本研究是一项回顾性观察研究,使用基于日本员工的健康保险理赔数据库(2005年1月1日至2013年12月31日)。根据体检细节分析登记为吸烟者的个体。比较了每年每位男性吸烟者有≥1次SCOV理赔与无理赔者的人均医疗费用(PPPY)。我们还评估了男性和女性吸烟者的SCOV次数是否会影响医疗费用。索引年份是首次SCOV理赔后的年份以及首次登记为吸烟者后的年份(非SCOV组)。使用回归分析计算医疗费用并根据基线费用进行调整。
在索引年份-1,有SCOV的男性吸烟者(n = 5608)的PPPY医疗费用比无SCOV的男性吸烟者(n = 81721)高约323.01美元(截至2017年11月为36500日元);然而,到第6年时费用相似。从第4至6年,SCOV的PPPY医疗费用低于调整后的非SCOV组。对于SCOV组中的2576名男性和女性吸烟者,进行1、2、3、4和5次SCOV前后医疗费用的平均增长率分别为58%、44%、50%、41%和34%。
该数据库包含65岁以上个体的有限数据。仅评估了基于理赔数据而非其他结果的SCOV。
首次SCOV后的短期内医疗费用下降。参加更多次数的SCOV与较低的医疗费用增长率相关。